Haseeb Rahman
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Haseeb Rahman has a total of 104 co-authors. Here are the top co-authors by number of shared publications:
- Divaka Perera
School of Cardiovascular Medicine and Sciences, St Thomas’ Hospital Campus, King’s College London, United Kingdom (D.P.).
15 shared publications - Ozan Mehmet Demir
British Heart Foundation Centre of Excellence, King’s College London, United Kingdom (O.M.D., H.R., D.P.).
12 shared publications - Aish Sinha
British Heart Foundation Centre of Excellence at the School of Cardiovascular Medicine and Sciences, King’s College London, United Kingdom (H.R., A.S., D.P.).
8 shared publications Divaka Perera
8 shared publications- Amedeo Chiribiri
Guy’s and St Thomas’ Hospital & School of Biomedical Engineering and Imaging Sciences, King’s College London Department of Cardiology Westminster Bridge Road, London SE1 7EH
7 shared publications Aish Sinha
6 shared publications
Latest Publications
- 19 August 2025
- Published by Wolters Kluwer Health in Circulation: Cardiovascular Interventions
- p. e015752
Response by Demir et al to Letter Regarding Article, “Pressure Derived Indices in the Left Main Coronary Artery: Insights From Comprehensive In Vivo Hemodynamic Studies of Diseased and Unobstructed Vessels”
- 19 August 2025
- Published by Wolters Kluwer Health in Circulation: Cardiovascular Interventions
- p. e015752
Response by Demir et al to Letter Regarding Article, “Pressure Derived Indices in the Left Main Coronary Artery: Insights From Comprehensive In Vivo Hemodynamic Studies of Diseased and Unobstructed Vessels”
- 6 August 2025
- Published by Elsevier in JACC: Cardiovascular Interventions
- Vol. 18 (17) , 2189-2191
Antianginal Therapy in Patients With Impaired Coronary Flow Reserve but Normal Minimal Microvascular Resistance
- 6 August 2025
- Published by Elsevier in JACC: Cardiovascular Interventions
- Vol. 18 (17) , 2189-2191
Antianginal Therapy in Patients With Impaired Coronary Flow Reserve but Normal Minimal Microvascular Resistance
- 1 August 2025
- Published by Wolters Kluwer Health in Circulation: Cardiovascular Interventions
- Vol. 18 (8) , e015677
More Is Not Always Better: Reassessing Acetylcholine Provocation in the Diagnosis of Coronary Vasospasm
- 1 August 2025
- Published by Wolters Kluwer Health in Circulation: Cardiovascular Interventions
- Vol. 18 (8) , e015677
More Is Not Always Better: Reassessing Acetylcholine Provocation in the Diagnosis of Coronary Vasospasm
- Open Access
- 1 July 2025
- Published by Wolters Kluwer Health in Circulation: Cardiovascular Interventions
- Vol. 18 (7) , e015320
Pressure-Derived Indices in the Left Main Coronary Artery: Insights From Comprehensive In Vivo Hemodynamic Studies of Diseased and Unobstructed Vessels
BACKGROUND: Pressure-based physiological evaluation of coronary artery disease is well established, but its application is limited in left main coronary artery (LMCA) disease. Our aim was to investigate whether pressure-based indices are comparable in the left anterior descending (LAD) and left circumflex artery (LCx) branches of the LMCA, and if discordance is due to differences in microvascular function in these territories. METHODS: Simultaneous measurements of coronary pressure and flow were made in patients with (1) isolated LMCA disease and (2) unobstructed coronary arteries. Fractional flow reserve, instantaneous wave-free ratio, and microvascular resistance reserve values in the LAD were compared with those of the LCx. RESULTS: A total of 80 patients were enrolled (mean age 65±10 years, 56% male). In those with isolated LMCA disease, fractional flow reserve in the LAD was lower than in the LCx (0.74±0.11 versus 0.81±0.11; P P P P P =0.56). Similarly, microvascular resistance reserve in the LCx territory was comparable between cohorts ( P =0.88). CONCLUSIONS: Microvascular resistance in the LAD is lower than in the LCx territory. Consequently, fractional flow reserve and nonhyperemic pressure-derived indices are lower in the LAD than the LCx. These findings have important implications for how LMCA atheroma should be assessed in clinical practice and also suggest the need for territory-specific thresholds for defining abnormal microvascular function and epicardial conductance.
- 1 July 2025
- Published by Wolters Kluwer Health in Circulation: Cardiovascular Interventions
- Vol. 18 (7) , e015320
Open AccessPressure-Derived Indices in the Left Main Coronary Artery: Insights From Comprehensive In Vivo Hemodynamic Studies of Diseased and Unobstructed Vessels
BACKGROUND: Pressure-based physiological evaluation of coronary artery disease is well established, but its application is limited in left main coronary artery (LMCA) disease. Our aim was to investigate whether pressure-based indices are comparable in the left anterior descending (LAD) and left circumflex artery (LCx) branches of the LMCA, and if discordance is due to differences in microvascular function in these territories. METHODS: Simultaneous measurements of coronary pressure and flow were made in patients with (1) isolated LMCA disease and (2) unobstructed coronary arteries. Fractional flow reserve, instantaneous wave-free ratio, and microvascular resistance reserve values in the LAD were compared with those of the LCx. RESULTS: A total of 80 patients were enrolled (mean age 65±10 years, 56% male). In those with isolated LMCA disease, fractional flow reserve in the LAD was lower than in the LCx (0.74±0.11 versus 0.81±0.11; P P P P P =0.56). Similarly, microvascular resistance reserve in the LCx territory was comparable between cohorts ( P =0.88). CONCLUSIONS: Microvascular resistance in the LAD is lower than in the LCx territory. Consequently, fractional flow reserve and nonhyperemic pressure-derived indices are lower in the LAD than the LCx. These findings have important implications for how LMCA atheroma should be assessed in clinical practice and also suggest the need for territory-specific thresholds for defining abnormal microvascular function and epicardial conductance.
- 4 June 2025
- Published by Elsevier in JACC: Cardiovascular Interventions
- Vol. 18 (13) , 1706-1708
Comparing Coronary Physiology Responses to Adenosine, Dobutamine, and Physical Exercise in Myocardial Bridges
- 4 June 2025
- Published by Elsevier in JACC: Cardiovascular Interventions
- Vol. 18 (13) , 1706-1708
Comparing Coronary Physiology Responses to Adenosine, Dobutamine, and Physical Exercise in Myocardial Bridges
- Open Access
- 6 March 2025
- Published by Springer Nature
Exploring the link between coronary microvascular dysfunction and heart failure with preserved ejection fraction
- 6 March 2025
- Published by Springer Nature
Open AccessExploring the link between coronary microvascular dysfunction and heart failure with preserved ejection fraction
- 8 January 2025
- Published by Elsevier in JACC: Cardiovascular Interventions
- Vol. 18 (2) , 279-281
Concordance and Accuracy of Pressure Wire–Derived Indexes in Left Main Coronary Artery Disease
- 8 January 2025
- Published by Elsevier in JACC: Cardiovascular Interventions
- Vol. 18 (2) , 279-281
Concordance and Accuracy of Pressure Wire–Derived Indexes in Left Main Coronary Artery Disease
- Open Access
- 1 September 2024
- Published by Wolters Kluwer Health in Circulation: Cardiovascular Interventions
- Vol. 17 (9) , e014477
Microvascular Resistance Reserve Predicts Myocardial Ischemia and Response to Therapy in Patients With Angina and Nonobstructive Coronary Arteries
- 1 September 2024
- Published by Wolters Kluwer Health in Circulation: Cardiovascular Interventions
- Vol. 17 (9) , e014477
Open AccessMicrovascular Resistance Reserve Predicts Myocardial Ischemia and Response to Therapy in Patients With Angina and Nonobstructive Coronary Arteries
- 13 August 2024
- Published by Wolters Kluwer Health in Circulation
- Vol. 150 (7) , e156-e157
Response by Sinha et al to Letter Regarding Article, “ChaMP-CMD: A Phenotype-Blinded, Randomized Controlled, Cross-Over Trial”
- 13 August 2024
- Published by Wolters Kluwer Health in Circulation
- Vol. 150 (7) , e156-e157
Response by Sinha et al to Letter Regarding Article, “ChaMP-CMD: A Phenotype-Blinded, Randomized Controlled, Cross-Over Trial”